Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by the European Forum for Research and Education in Allergy and Airways Diseases.

Chest·2026
Same author

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Frontiers in allergy·2025
Same author

A deep learning pipeline for systematic and accurate vertebral fracture reporting in computed tomography.

Clinical radiology·2025
Same author

New-generation 0.55T MRI in patients with total hip arthroplasty: a comparison with 1.5T MRI.

Clinical radiology·2024
Same author

EUFOREA summit in Brussels 2023: <i>inspiring the future of allergy & respiratory care</i>.

Frontiers in allergy·2023

Related Experiment Video

Updated: Jun 18, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

[Specific immunotherapy in hay fever: a practical overview].

D Harder1, P Schmid-Grendelmeier

  • 1Brunnenhof-Praxis, Gäuggelistrasse 20, Chur. dominik.harder@hin.ch

Praxis
|November 18, 2009
PubMed
Summary

Allergen-specific immunotherapy (SIT) effectively treats pollinosis (hay fever), benefiting over 80% of patients when properly managed. Ongoing research aims to further enhance SIT

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine
  • Pharmacology

Background:

  • Pollinosis affects 20% of the Swiss population, with a significant increase in prevalence over the past century.
  • Current diagnosis relies on medical history, skin tests, and serum-specific IgE.
  • Standard treatments include allergen avoidance, medication, and allergen-specific immunotherapy (SIT).

Purpose of the Study:

  • To review the efficacy and current status of allergen-specific immunotherapy for pollinosis.
  • To highlight factors critical for successful SIT.
  • To discuss emerging approaches for improving SIT.

Main Methods:

  • Review of existing literature on pollinosis diagnosis and treatment.
  • Analysis of factors influencing SIT success, including patient selection and application regimens.

More Related Videos

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Experiment Videos

Last Updated: Jun 18, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

  • Exploration of novel diagnostic and therapeutic strategies, such as component-resolved diagnosis and molecular technologies.
  • Main Results:

    • SIT is highly effective, providing benefits for over 80% of pollinosis patients under optimal conditions.
    • Proper patient selection, allergen extract choice, adapted regimens, and patient guidance are crucial for successful SIT.
    • Component-resolved diagnosis offers a more precise diagnostic approach.

    Conclusions:

    • Allergen-specific immunotherapy is a beneficial treatment for a majority of pollinosis patients.
    • Optimizing patient and allergen selection, application, and guidance enhances SIT efficacy.
    • Emerging molecular technologies and modified application regimens hold promise for improving SIT's effectiveness, safety, and patient acceptance.